Helene Le Buannec

Title: Helene Le Buannec: Innovator in Immunogenic Products

Introduction

Helene Le Buannec is a prominent inventor based in Paris, France. She has made significant contributions to the field of immunology, particularly in the development of stable immunogenic products. With a total of two patents to her name, her work focuses on enhancing the induction of antibodies against various antigenic proteins.

Latest Patents

Le Buannec's latest patents include a stable immunogenic product comprising antigenic heterocomplexes. This invention is designed to induce antibodies against one or more antigenic proteins in a subject. The product is characterized by its proteinaceous immunogenic heterocomplexes, which are formed through associations between antigenic protein molecules and proteinaceous carrier molecules. Notably, less than 40% of the antigenic proteins are linked to the carrier molecules by a covalent bond, which is a key feature of her innovation.

Career Highlights

Helene Le Buannec is currently associated with Neovacs, a company that focuses on developing innovative immunotherapies. Her work at Neovacs has positioned her as a leader in the field of immunogenic research.

Collaborations

Le Buannec collaborates with various professionals in her field, including her coworker Daniel Zagury. Their combined expertise contributes to the advancement of immunogenic products and therapies.

Conclusion

Helene Le Buannec's contributions to immunology through her patents and work at Neovacs highlight her role as an influential inventor. Her innovative approaches to stable immunogenic products are paving the way for advancements in antibody induction.